Business News

HistoSonics Announces Published Results of Phase I Liver Tumor Trial

As Company Advances Planning for FDA Submission and Future Growth MINNEAPOLIS, Sept. 19, 2022 /PRNewswire/ -- HistoSonics, (www.histosonics.com), the developer and manufacturer of a completely non-invasive platform and proprietary sonic beam therapy, announced today the publication of results from their prospective Phase I clinical trial, named the THERESA Trial, conducted in...

Lightricks Partners With Shutterstock for Video Training Data to Advance Open Source LTXV Video AI Generative Video Model

Shutterstocks' partnership with Lightricks is the first of a new data licensing approach that builds new ways for training AI models JERUSALEM and NEW YORK, Dec. 14, 2024 /PRNewswire/ -- Lightricks, a global leader of AI-powered creative technology, today announced it is partnering with Shutterstock, Inc. (NYSE: SSTK) to license and...

RoboSense Launches EMX: Industry-Leading 192-Beam Digital Automotive LiDAR, Entering Customizable Digital Era

SHENZHEN, China, April 21, 2025 /PRNewswire/ -- RoboSense, a global leader in AI-driven robotics technology platforms, officially introduced EMX, its latest 192-beam high-performance automotive digital LiDAR. EMX sets a new industry benchmark, accelerating the mass adoption of digital LiDAR with unmatched performance, integration, and customization capabilities. Product Image – EMX EMX: 192-Beam...

Amcor to Sell Interest in BCNA Joint Venture for $122 Million

Sale not expected to impact FY25 financial outlookProceeds to be used to reduce debt ZURICH, Nov. 1, 2024 /PRNewswire/ -- Amcor (NYSE: AMCR, ASX: AMC), a global leader in developing and producing responsible packaging solutions, announced today it has entered into an agreement to sell its 50% interest in Bericap North America (BCNA) for $122 million. Established in 1997, BCNA...

Travel Trailblazers: Top Global Finalists Shortlisted for Trip.com Group’s Tourism Innovation Awards

Shortlisted nominees include Las Vegas' the Afterlife show at the Sphere, London's ABBA Voyage, Giza's Grand Egyptian Museum and Tokyo's teamLab Borderless Final top ten award winners to be announced end July, with a total prize pool of USD $1.4 million SINGAPORE, July 11, 2025...

NYSE Content Advisory: Pre-Market Update + HawkEye 360 Acquires ISA with $150 Million in Financing

NEW YORK, Dec. 19, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.    NYSE Content Advisory: Pre-Market Update + HawkEye 360 Acquires ISA with $150...

Sports Titan Pte Ltd is Partnering Up with HokuApps to Re-Engineer its Business Workflows and Processes to Drive Digital Transformation in a Post-Pandemic World

Together they have built a fully integrated sports and wellness enterprise mobility solution that will help streamline business operations, improve coach and trainee management and boosts sales and revenue as a whole. SINGAPORE, Jan. 27, 2023 /PRNewswire/ -- HokuApps, a global player in the next-generation enterprise mobility solutions, is pleased to announce that they are selected as the preferred technology...

DPC Dash Ltd Announces Full Year 2025 Financial Results

Revenues increased to RMB5.38 billion, representing 24.8% year-over-year growth Adjusted net profit reached RMB187.9 million, representing 43.3% year-over-year growth Store-level operating profit grew by 18.5%; Adjusted group EBITDA increased by 28.2% EPS increased 157.1% YoY to RMB1.08, Diluted EPS increased 150.0% YoY to RMB1.05 HONG KONG, March 25, 2026 /PRNewswire/ --...

Mayne Pharma and Mithra Announce TGA Approval of NEXTSTELLIS® Oral Contraceptive

ADELAIDE, Australia, Nov. 30, 2021 /PRNewswire/ -- Mayne Pharma Group Limited (ASX: MYX) and Mithra Pharmaceuticals, SA (Euronext Brussels: MITRA) are very pleased to announce the Therapeutic Goods Administration (TGA) has approved the novel combined oral contraceptive NEXTSTELLIS® (14.2 mg of estetrol and 3 mg drospirenone tablets). Mayne Pharma anticipates the commercial launch of NEXTSTELLIS by mid-2022 supported by...

Qiming Venture Partners’ Portfolio Company UBTech Listed on Hong Kong Stock Exchange

UBTech is the first humanoid robot company to go public on HKEx Qiming is UBTech's early institutional investor, exclusively investing in its Series A round in 2015 UBTech's listing is Qiming's eighth IPO in 2023 SHANGHAI, Dec. 29, 2023 /PRNewswire/ -- Qiming Venture Partners' portfolio company UBTech, a humanoid robot leader in China, successfully debuted on...
- Advertisement -

Recent Posts